Robotic Arm-assisted THA Vs. Conventional THA in Legg-Calvé-Perthes Disease

Comparison of Robotic Arm-assisted THA and Conventional Manual THA in Patients With Legg-Calvé-Perthes Disease: a Prospective Cohort Study

Flat hip, also called Legg-Calvé-Perthes disease, is clinically characterized by flattened femoral head, shortened femoral neck, and a center of rotation of the femoral head lower than the apex of the greater trochanter. Joint replacement is difficult, with high intraoperative and postoperative complications. Especially, issues such as unequal limb length, postoperative dislocation, postoperative neurological damage, and prosthesis impact have always plagued clinical practice.

The robotic arm-assisted joint replacement technology has been developed and clinically applied for over 10 years, but it was not until the past 3 years that it began to be widely implemented worldwide. Existing research data indicates that robotic arm-assisted joint replacement technology can significantly improve the placement of prostheses and lower limb force lines in patients, and improve their short-term clinical prognosis. However, its application in complex hips, such as flat hip, is limited. More relevant literature is needed to further enrich people's understanding of this technology. In theory, robot assisted technology can solve many challenges faced in flat hip replacement.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310009
        • Second Affiliated Hospital of Zhejiang University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients with Legg-Calvé-Perthes disease and accept total hip replacement in our center

Exclusion Criteria:

  • infection, cannot complete follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: conventional total hip replacement
applying conventional total hip replacement in patients with Legg-Calvé-Perthes disease
applying conventional total hip replacement in patients with Legg-Calvé-Perthes disease
Experimental: robotic arm-assisted total hip replacement
applying robotic arm-assisted total hip replacement in patients with Legg-Calvé-Perthes disease
using robotic total hip replacement in patients with Legg-Calvé-Perthes disease

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
inclination angle
Time Frame: 2 days after surgery
The inclination angle in total hip replacement (THR), also called the abduction angle , refers to the angle at which the acetabular cup component is tilted relative to the horizontal plane when viewed on an anteroposterior (AP) pelvic X-ray.
2 days after surgery
anteversion angle
Time Frame: 2 days after surgery
The anteversion angle in total hip replacement (THR) refers to the forward tilt (rotation) of the acetabular cup component around its vertical axis. It determines whether the cup's opening faces more forward or backward relative to the pelvis.
2 days after surgery
Hospital for Special Surgery Score score (HSS score)
Time Frame: before the surgery, 1 week after surgery, 1 month after surgery, 6 months after surgery, 1 year after surgery
The maximum values is 100, and the minimum value is 0. Higher scores means a better outcome.
before the surgery, 1 week after surgery, 1 month after surgery, 6 months after surgery, 1 year after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
operation duration
Time Frame: during the operation
The operation duration (also called operative time or surgical time ) refers to the total time taken to complete a surgical procedure.
during the operation
blood loss
Time Frame: during the operation
The amount of blood loss during the surgery.
during the operation
Visual Analogue Scale score (VAS score)
Time Frame: before the surgery, 1 week after surgery, 1 month after surgery, 6 months after surgery, 1 year after surgery
The maximum value is 10, and the minimum value is 0. Lower score means a better outcome.
before the surgery, 1 week after surgery, 1 month after surgery, 6 months after surgery, 1 year after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 28, 2025

Primary Completion (Estimated)

July 28, 2027

Study Completion (Estimated)

July 28, 2027

Study Registration Dates

First Submitted

August 7, 2025

First Submitted That Met QC Criteria

August 13, 2025

First Posted (Actual)

August 14, 2025

Study Record Updates

Last Update Posted (Actual)

August 14, 2025

Last Update Submitted That Met QC Criteria

August 13, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Legg-Calvé-Perthes Disease

Clinical Trials on conventional total hip replacement

Subscribe